StockWatch
·
Filing
Q3

Veerhealth Care Limited

VEERHEALTHFY2614 Feb 2026
Revenue+82.4%
Net Profit+60.5%
OPM17.00%

P&L

Quarterly Standalone

Revenue
+82.4%7.26
Expenditure
+67.3%6.47
Net Profit
+60.5%0.40
NPM 5.81%-3.0%EPS ₹0.20+53.9%

vs Q2 FY26

Veerhealth Care Reports 474.18% YoY Growth in PAT and 73.13% in Total Income in Q3FY26

16 Feb 2026 · 16 Feb, 5:42 pm

Summary

Veerhealth Care Limited reported financial updates for Q3 FY26.

Key Highlights

  1. 1

    rev: 6.96

  2. 2

    rev yoy: 73.13%

  3. 3

    ebitda: 0.94

  4. 4

    ebitda yoy: 181.44%

  5. 5

    ebitda margin: 13.36%

  6. 6

    pat: 0.40

  7. 7

    pat yoy: 474.18%

  8. 8

    pat margin: 5.81%

Management Comments

B

Bhavin Shah

I am delighted with the strides we have made in Q3 FY26, driven by our consistent focus on expanding our international footprint and strengthening our domestic presence. The growth in our Export Sales and the addition of new product categories have significantly bolstered our position in the global and local markets. Going ahead we expect to maintain the high growth rates which we have delivered in this Quarter. Our ability to secure multiple high-value export orders, including those from top institutional suppliers, underscores the trust in our product quality and commitment to excellence. The expansion of our manufacturing footprint further reflects our proactive approach to meeting growing demand and enhancing our production capabilities. These achievements are a testament to our strategy and pave the way for sustained growth and value creation in the coming quarters.

Informational and educational content only. Not investment advice.